Toxicol Res.  2012 Dec;28(4):235-240.

Biodistribution of 99mTc Tricarbonyl Glycine Oligomers

Affiliations
  • 1Radioisotope Science Laboratory, Korea Atomic Energy Research Institute, Jeonbuk, Korea. parksh@kaeri.re.kr

Abstract

99mTc tricarbonyl glycine monomers, trimers, and pentamers were synthesized and evaluated for their radiolabeling and in vivo distribution characteristics. We synthesized a 99mTc-tricarbonyl precursor with a low oxidation state (I). 99mTc(CO)3(H2O)3 + was then made to react with monomeric and oligomeric glycine for the development of bifunctional chelating sequences for biomolecules. Labeling yields of 99mTc-tricarbonyl glycine monomers and oligomers were checked by high-performance liquid chromatography. The labeling yields of 99mTc-tricarbonyl glycine and glycine oligomers were more than 95%. We evaluated the characteristics of 99mTc-tricarbonyl glycine oligomers by carrying out a lipophilicity test and an imaging study. The octanol-water partition coefficient of 99mTc tricarbonyl glycine oligomers indicated hydrophilic properties. Single-photon emission computed tomography imaging of 99mTc-tricarbonyl glycine oligomers showed rapid renal excretion through the kidneys with a low uptake in the liver, especially of 99mTc tricarbonyl triglycine. Furthermore, we verified that the addition of triglycine to prototype biomolecules (AGRGDS and RRPYIL) results in the improvement of radiolabeling yield. From these results, we conclude that triglycine has good characteristics for use as a bifunctional chelating sequence for a 99mTc-tricarbonyl-based biomolecular imaging probe.

Keyword

99mTc-tricarbonyl precursor; Glycine oligomer; Imaging moiety; Biomolecule tracing

MeSH Terms

Chromatography, Liquid
Glycine
Kidney
Lifting
Liver
Oligopeptides
Pentamidine
Tomography, Emission-Computed
Glycine
Oligopeptides
Pentamidine
Full Text Links
  • TR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr